Skip to main content
Erschienen in: Neurological Sciences 8/2021

26.11.2020 | Original Article

Psychometric features of Neuropathic Pain Symptom Inventory in Iranian people with Parkinson’s disease

verfasst von: Ghorban Taghizadeh, Carmen Rodriguez-Blazquez, Mohammad Taghi Joghataei, Sepideh Goudarzi, Sayed Amir Hasan Habibi, Merat Bakhsheshi, Maryam Mehdizadeh, Seyed-Mohammad Fereshtehnejad

Erschienen in: Neurological Sciences | Ausgabe 8/2021

Einloggen, um Zugang zu erhalten

Abstract

Objective

Neuropathic pain is a type of pain reported in people with Parkinson’s disease. There are various scales to evaluate the characteristics of this kind of pain. The purpose of this study was to investigate the psychometric properties of the Neuropathic Pain Symptom Inventory (NPSI), a specific scale that measures neuropathic pain in Iranian people with Parkinson’s disease.

Method

Four hundred forty-seven individuals with Parkinson’s disease were recruited in the study. Acceptability, internal consistency (Cronbach’s alpha), and test-retest reliability (intraclass correlation coefficient, ICC) of NPSI were calculated. Dimensionality was examined through exploratory factor analysis. For convergent validity, correlations of NPSI with Douleur Neuropathic 4, Brief Pain Inventory, King’s Pain Parkinson disease Scale, and Visual Analog Scale-Pain were used. Discriminative validity and sensitivity to change between On- and Off- medication states were analyzed.

Results

A marked floor effect was observed for this scale (64.2%). Cronbach’s alpha and ICC were 0.90 and 0.87, respectively. Items of NPSI were placed in 4 factors. A moderate to the strong association (rs = 0.55 to 0.85) between NPSI and other scales was obtained. The results of discriminative validity and sensitivity to change indicate the ability of NPSI to show differences between medication states.

Conclusion

The results of this study suggest that NPSI has acceptable reliability, validity, and sensitivity to change, indicating that this scale is suitable for measuring neuropathic pain in Iranian people with Parkinson’s disease.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Beiske A, Loge JH, Rønningen A, Svensson E (2009) Pain in Parkinson’s disease: prevalence and characteristics. PAIN® 141(1–2):173–177CrossRef Beiske A, Loge JH, Rønningen A, Svensson E (2009) Pain in Parkinson’s disease: prevalence and characteristics. PAIN® 141(1–2):173–177CrossRef
2.
Zurück zum Zitat Gallagher DA, Lees AJ, Schrag A (2010) What are the most important nonmotor symptoms in patients with Parkinson's disease and are we missing them? Mov Disord 25(15):2493–2500CrossRef Gallagher DA, Lees AJ, Schrag A (2010) What are the most important nonmotor symptoms in patients with Parkinson's disease and are we missing them? Mov Disord 25(15):2493–2500CrossRef
3.
Zurück zum Zitat Quittenbaum BH, Grahn B (2004) Quality of life and pain in Parkinson’s disease: a controlled cross-sectional study. Parkinsonism Relat Disord 10(3):129–136CrossRef Quittenbaum BH, Grahn B (2004) Quality of life and pain in Parkinson’s disease: a controlled cross-sectional study. Parkinsonism Relat Disord 10(3):129–136CrossRef
4.
Zurück zum Zitat Marsala SZ, Tinazzi M, Vitaliani R, Recchia S, Fabris F, Marchini C et al (2011) Spontaneous pain, pain threshold, and pain tolerance in Parkinson’s disease. J Neurol 258(4):627–633CrossRef Marsala SZ, Tinazzi M, Vitaliani R, Recchia S, Fabris F, Marchini C et al (2011) Spontaneous pain, pain threshold, and pain tolerance in Parkinson’s disease. J Neurol 258(4):627–633CrossRef
5.
Zurück zum Zitat Brefel-Courbon C, Payoux P, Thalamas C, Ory F, Quelven I, Chollet F, Montastruc JL, Rascol O (2005) Effect of levodopa on pain threshold in Parkinson's disease: a clinical and positron emission tomography study. Mov Disord 20(12):1557–1563CrossRef Brefel-Courbon C, Payoux P, Thalamas C, Ory F, Quelven I, Chollet F, Montastruc JL, Rascol O (2005) Effect of levodopa on pain threshold in Parkinson's disease: a clinical and positron emission tomography study. Mov Disord 20(12):1557–1563CrossRef
6.
Zurück zum Zitat Slaoui T, Mas-Gerdelat A, Ory-Magne F, Rascol O, Brefel-Courbon C (2007) Levodopa modifies pain thresholds in Parkinson’s disease patients. Rev Neurol 163(1):66–71CrossRef Slaoui T, Mas-Gerdelat A, Ory-Magne F, Rascol O, Brefel-Courbon C (2007) Levodopa modifies pain thresholds in Parkinson’s disease patients. Rev Neurol 163(1):66–71CrossRef
7.
Zurück zum Zitat Mylius V, Engau I, Teepker M, Stiasny-Kolster K, Schepelmann K, Oertel WH, Lautenbacher S, Moller JC (2009) Pain sensitivity and descending inhibition of pain in Parkinson’s disease. J Neurol Neurosurg Psychiatry 80(1):24–28CrossRef Mylius V, Engau I, Teepker M, Stiasny-Kolster K, Schepelmann K, Oertel WH, Lautenbacher S, Moller JC (2009) Pain sensitivity and descending inhibition of pain in Parkinson’s disease. J Neurol Neurosurg Psychiatry 80(1):24–28CrossRef
8.
Zurück zum Zitat Geroin C, Gandolfi M, Bruno V, Smania N, Tinazzi M (2016) Integrated approach for pain management in Parkinson disease. Curr Neurol Neurosci Rep 16(4):28CrossRef Geroin C, Gandolfi M, Bruno V, Smania N, Tinazzi M (2016) Integrated approach for pain management in Parkinson disease. Curr Neurol Neurosci Rep 16(4):28CrossRef
9.
Zurück zum Zitat Ha AD, Jankovic J (2012) Pain in Parkinson’s disease. Mov Disord 27(4):485–491CrossRef Ha AD, Jankovic J (2012) Pain in Parkinson’s disease. Mov Disord 27(4):485–491CrossRef
10.
Zurück zum Zitat Treede R-D, Jensen TS, Campbell JN, Cruccu G, Dostrovsky J, Griffin J et al (2008) Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology. 70(18):1630–1635CrossRef Treede R-D, Jensen TS, Campbell JN, Cruccu G, Dostrovsky J, Griffin J et al (2008) Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology. 70(18):1630–1635CrossRef
11.
Zurück zum Zitat Moreno C, Hernández-Beltrán N, Munévar D, Gutiérrez-Alvarez A (2012) Central neuropathic pain in Parkinson’s disease. Neurología 27(8):500–503CrossRef Moreno C, Hernández-Beltrán N, Munévar D, Gutiérrez-Alvarez A (2012) Central neuropathic pain in Parkinson’s disease. Neurología 27(8):500–503CrossRef
12.
Zurück zum Zitat Brefel-Courbon C, Ory-Magne F, Thalamas C, Payoux P, Rascol O (2013) Nociceptive brain activation in patients with neuropathic pain related to Parkinson’s disease. Parkinsonism Relat Disord 19(5):548–552CrossRef Brefel-Courbon C, Ory-Magne F, Thalamas C, Payoux P, Rascol O (2013) Nociceptive brain activation in patients with neuropathic pain related to Parkinson’s disease. Parkinsonism Relat Disord 19(5):548–552CrossRef
13.
Zurück zum Zitat Rana A, Khan T, Galange P, Khan A, Yousuf M (2012) Effects of pain on activities of daily living and functioning in Parkinson’s disease patients. Transl Neurosci 3(4):328–333CrossRef Rana A, Khan T, Galange P, Khan A, Yousuf M (2012) Effects of pain on activities of daily living and functioning in Parkinson’s disease patients. Transl Neurosci 3(4):328–333CrossRef
14.
Zurück zum Zitat Rana AQ, Kabir A, Jesudasan M, Siddiqui I, Khondker S (2013) Pain in Parkinson’s disease: analysis and literature review. Clin Neurol Neurosurg 115(11):2313–2317CrossRef Rana AQ, Kabir A, Jesudasan M, Siddiqui I, Khondker S (2013) Pain in Parkinson’s disease: analysis and literature review. Clin Neurol Neurosurg 115(11):2313–2317CrossRef
15.
Zurück zum Zitat Bouhassira D, Attal N, Fermanian J, Alchaar H, Gautron M, Masquelier E, Rostaing S, Lanteri-Minet M, Collin E, Grisart J, Boureau F (2004) Development and validation of the neuropathic pain symptom inventory. Pain. 108(3):248–257CrossRef Bouhassira D, Attal N, Fermanian J, Alchaar H, Gautron M, Masquelier E, Rostaing S, Lanteri-Minet M, Collin E, Grisart J, Boureau F (2004) Development and validation of the neuropathic pain symptom inventory. Pain. 108(3):248–257CrossRef
16.
Zurück zum Zitat Padua L, Briani C, Jann S, Nobile-Orazio E, Pazzaglia C, Morini A, Mondelli M, Ciaramitaro P, Cavaletti G, Cocito D, Fazio R, Santoro L, Galeotti F, Carpo M, Plasmati R, Benedetti L, Schenone A, Marchettini P, Cruccu G (2009) Validation of the Italian version of the neuropathic pain symptom inventory in peripheral nervous system diseases. Neurol Sci 30(2):99–106CrossRef Padua L, Briani C, Jann S, Nobile-Orazio E, Pazzaglia C, Morini A, Mondelli M, Ciaramitaro P, Cavaletti G, Cocito D, Fazio R, Santoro L, Galeotti F, Carpo M, Plasmati R, Benedetti L, Schenone A, Marchettini P, Cruccu G (2009) Validation of the Italian version of the neuropathic pain symptom inventory in peripheral nervous system diseases. Neurol Sci 30(2):99–106CrossRef
17.
Zurück zum Zitat Villoria J, Rodríguez M, Berro MJ, Stern A, Sánchez-Magro I (2011) Psychometric validation of the neuropathic pain symptom inventory for its use in Spanish. J Pain Symptom Manag 42(1):134–146CrossRef Villoria J, Rodríguez M, Berro MJ, Stern A, Sánchez-Magro I (2011) Psychometric validation of the neuropathic pain symptom inventory for its use in Spanish. J Pain Symptom Manag 42(1):134–146CrossRef
18.
Zurück zum Zitat Sommer C, Richter H, Rogausch JP, Frettlöh J, Lungenhausen M, Maier C (2011) A modified score to identify and discriminate neuropathic pain: a study on the German version of the neuropathic pain symptom inventory (NPSI). BMC Neurol 11(1):104CrossRef Sommer C, Richter H, Rogausch JP, Frettlöh J, Lungenhausen M, Maier C (2011) A modified score to identify and discriminate neuropathic pain: a study on the German version of the neuropathic pain symptom inventory (NPSI). BMC Neurol 11(1):104CrossRef
19.
Zurück zum Zitat de Andrade DC, Ferreira KA, Nishimura CM, Yeng LT, Batista AF, De Sá K et al (2011) Psychometric validation of the Portuguese version of the neuropathic pain symptoms inventory. Health Qual Life Outcomes 9(1):107CrossRef de Andrade DC, Ferreira KA, Nishimura CM, Yeng LT, Batista AF, De Sá K et al (2011) Psychometric validation of the Portuguese version of the neuropathic pain symptoms inventory. Health Qual Life Outcomes 9(1):107CrossRef
20.
Zurück zum Zitat Godefroy O, Fickl A, Roussel M, Auribault C, Bugnicourt JM, Lamy C, Canaple S, Petitnicolas G (2011) Is the Montreal Cognitive Assessment superior to the Mini-Mental State Examination to detect poststroke cognitive impairment? A study with neuropsychological evaluation. Stroke. 42(6):1712–1716CrossRef Godefroy O, Fickl A, Roussel M, Auribault C, Bugnicourt JM, Lamy C, Canaple S, Petitnicolas G (2011) Is the Montreal Cognitive Assessment superior to the Mini-Mental State Examination to detect poststroke cognitive impairment? A study with neuropsychological evaluation. Stroke. 42(6):1712–1716CrossRef
21.
Zurück zum Zitat Razavi D, Delvaux N, Farvacques C, Robaye E (1990) Screening for adjustment disorders and major depressive disorders in cancer in-patients. Br J Psychiatry 156(1):79–83CrossRef Razavi D, Delvaux N, Farvacques C, Robaye E (1990) Screening for adjustment disorders and major depressive disorders in cancer in-patients. Br J Psychiatry 156(1):79–83CrossRef
22.
Zurück zum Zitat Morris S, Morris ME, Iansek R (2001) Reliability of measurements obtained with the timed “up & go” test in people with Parkinson disease. Phys Ther 81(2):810–818CrossRef Morris S, Morris ME, Iansek R (2001) Reliability of measurements obtained with the timed “up & go” test in people with Parkinson disease. Phys Ther 81(2):810–818CrossRef
23.
Zurück zum Zitat Aaronson N, Acquadro C, Alonso J, Apolone G, Bucquet D, Bullinger M et al (1992) International quality of life assessment (IQOLA) project. Qual Life Res 1(5):349–351CrossRef Aaronson N, Acquadro C, Alonso J, Apolone G, Bucquet D, Bullinger M et al (1992) International quality of life assessment (IQOLA) project. Qual Life Res 1(5):349–351CrossRef
24.
Zurück zum Zitat Chaudhuri KR, Rizos A, Trenkwalder C, Rascol O, Pal S, Martino D, Carroll C, Paviour D, Falup-Pecurariu C, Kessel B, Silverdale M, Todorova A, Sauerbier A, Odin P, Antonini A, Martinez-Martin P, on behalf of EUROPAR and the IPMDS Non Motor PD Study Group (2015) King's Parkinson's disease pain scale, the first scale for pain in PD: an international validation. Mov Disord 30(12):1623–1631CrossRef Chaudhuri KR, Rizos A, Trenkwalder C, Rascol O, Pal S, Martino D, Carroll C, Paviour D, Falup-Pecurariu C, Kessel B, Silverdale M, Todorova A, Sauerbier A, Odin P, Antonini A, Martinez-Martin P, on behalf of EUROPAR and the IPMDS Non Motor PD Study Group (2015) King's Parkinson's disease pain scale, the first scale for pain in PD: an international validation. Mov Disord 30(12):1623–1631CrossRef
25.
Zurück zum Zitat Majedi H, Dehghani SS, Soleyman-Jahi S, Meibodi SAE, Mireskandari SM, Hajiaghababaei M et al (2017) Validation of the Persian version of the Brief Pain Inventory (BPI-P) in chronic pain patients. J Pain Symptom Manag 54(1):132–138 e2CrossRef Majedi H, Dehghani SS, Soleyman-Jahi S, Meibodi SAE, Mireskandari SM, Hajiaghababaei M et al (2017) Validation of the Persian version of the Brief Pain Inventory (BPI-P) in chronic pain patients. J Pain Symptom Manag 54(1):132–138 e2CrossRef
26.
Zurück zum Zitat Madani SP, Fateh HR, Forogh B, Fereshtehnejad SM, Ahadi T, Ghaboussi P, Bouhassira D, Raissi GR (2014) Validity and reliability of the Persian (Farsi) version of the DN 4 (Douleur Neuropathique 4 Questions) questionnaire for differential diagnosis of neuropathic from non-neuropathic pains. Pain Pract 14(5):427–436PubMed Madani SP, Fateh HR, Forogh B, Fereshtehnejad SM, Ahadi T, Ghaboussi P, Bouhassira D, Raissi GR (2014) Validity and reliability of the Persian (Farsi) version of the DN 4 (Douleur Neuropathique 4 Questions) questionnaire for differential diagnosis of neuropathic from non-neuropathic pains. Pain Pract 14(5):427–436PubMed
27.
Zurück zum Zitat Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE (2010) Systematic review of levodopa dose equivalency reporting in Parkinson’s disease. Mov Disord 25(15):2649–2653CrossRef Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE (2010) Systematic review of levodopa dose equivalency reporting in Parkinson’s disease. Mov Disord 25(15):2649–2653CrossRef
28.
Zurück zum Zitat Piedmont RL (2014) Inter-item correlations. Encyclopedia of quality of life and well-being research. 3303–4 Piedmont RL (2014) Inter-item correlations. Encyclopedia of quality of life and well-being research. 3303–4
29.
Zurück zum Zitat van Bloemendaal M, Kokkeler AM, van de Port IG (2012) The shuttle walk test: a new approach to functional walking capacity measurements for patients after stroke? Arch Phys Med Rehabil 93(1):163–166CrossRef van Bloemendaal M, Kokkeler AM, van de Port IG (2012) The shuttle walk test: a new approach to functional walking capacity measurements for patients after stroke? Arch Phys Med Rehabil 93(1):163–166CrossRef
30.
Zurück zum Zitat Rooney R (2006) Statistical evidence in medical trials: what do the data really tell us? Stephen D. Simon. OUP, 2006.£ 65. ISBN 0 19 856760 X. Oxford University Press Rooney R (2006) Statistical evidence in medical trials: what do the data really tell us? Stephen D. Simon. OUP, 2006.£ 65. ISBN 0 19 856760 X. Oxford University Press
31.
Zurück zum Zitat Gibbons JD, Chakraborti S (2011) Nonparametric statistical inference. Springer Gibbons JD, Chakraborti S (2011) Nonparametric statistical inference. Springer
32.
Zurück zum Zitat Pintér D, Forjaz MJ, Martinez-Martin P, Rodriguez-Blazquez C, Ayala A, Juhász A et al (2019) Which scale best detects treatment response of tremor in parkinsonism? J Parkinsons Dis (Preprint):1–8 Pintér D, Forjaz MJ, Martinez-Martin P, Rodriguez-Blazquez C, Ayala A, Juhász A et al (2019) Which scale best detects treatment response of tremor in parkinsonism? J Parkinsons Dis (Preprint):1–8
33.
Zurück zum Zitat Demetriou C, Ozer BU, Essau CA (2014) Self-report questionnaires. The encyclopedia of clinical psychology. 1–6 Demetriou C, Ozer BU, Essau CA (2014) Self-report questionnaires. The encyclopedia of clinical psychology. 1–6
34.
Zurück zum Zitat Antonini A, Tinazzi M, Abbruzzese G, Berardelli A, Chaudhuri K, Defazio G et al (2018) Pain in Parkinson’s disease: facts and uncertainties. Eur J Neurol 25(7):917–e69CrossRef Antonini A, Tinazzi M, Abbruzzese G, Berardelli A, Chaudhuri K, Defazio G et al (2018) Pain in Parkinson’s disease: facts and uncertainties. Eur J Neurol 25(7):917–e69CrossRef
Metadaten
Titel
Psychometric features of Neuropathic Pain Symptom Inventory in Iranian people with Parkinson’s disease
verfasst von
Ghorban Taghizadeh
Carmen Rodriguez-Blazquez
Mohammad Taghi Joghataei
Sepideh Goudarzi
Sayed Amir Hasan Habibi
Merat Bakhsheshi
Maryam Mehdizadeh
Seyed-Mohammad Fereshtehnejad
Publikationsdatum
26.11.2020
Verlag
Springer International Publishing
Erschienen in
Neurological Sciences / Ausgabe 8/2021
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-020-04941-1

Weitere Artikel der Ausgabe 8/2021

Neurological Sciences 8/2021 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.